Keyword Connections

fungal infections

Journals

7

1 European journal of medicinal chemistry

2 The New phytologist

3 Mycoses

4 ACS infectious diseases

5 Open forum infectious diseases

6 Nature

7 clinical microbiology and infection : the official publication of the european society of clinical microbiology and infectious diseases

Research Groups

0

No Research Group Connected

Bibliographies

56

1 Interactions between Immune Response to Fungal Infection and MicroRNAs; the Pioneer Tuners.

2 Multifaceted regulatory function of tomato SlTAF1 in the response to salinity stress.

3 Recurrent non-coding U1-snRNA mutations drive cryptic splicing in Shh medulloblastoma.

4 Voriconazole plus terbinafine combination antifungal therapy for invasive Lomentospora prolificans infections: analysis of 41 patients from the FungiScope® registry 2008-2019.

5 Antifungal potential of marine natural products.

6 Coccidioidomycosis in Patients Treated With Ruxolitinib.

7 antifungal prophylaxis in immunocompromised patients

8 catheter-related candidemia caused by <i>candida lipolytica</i> in a child with tubercular meningitis

9 prevalence of fungal infections using national health insurance data from 2009-2013, south korea

10 Ultradeformable Lipid Vesicles Localize Amphotericin B in the Dermis for the Treatment of Infectious Skin Diseases.

11 the burden of serious fungal infections in cameroon

12 The role of medical mycology societies in combating invasive fungal infections in low- and middle-income countries: A Nigerian model

13 Five-year China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study of invasive fungal infections caused by noncandidal yeasts: species distribution and azole susceptibility

14 New insights into the clinical characteristics and prognostic factors of pulmonary fungal infections from a retrospective study in Southwestern China

15 Liver fungal infections: an overview of the etiology and epidemiology in patients affected or not affected by oncohematologic malignancies

16 Burden and treatment patterns of invasive fungal infections in hospitalized patients in the Middle East: real-world data from Saudi Arabia and Lebanon

17 A critical appraisal of once-daily topical luliconazole for the treatment of superficial fungal infections

18 Prevention of invasive fungal infections in immunocompromised patients: the role of delayed-release posaconazole

19 Profile of isavuconazole and its potential in the treatment of severe invasive fungal infections

20 Safety and efficacy of liposomal amphotericin B for the empirical therapy of invasive fungal infections in immunocompromised patients

21 Update on the optimal use of voriconazole for invasive fungal infections

22 Five-year China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study of invasive fungal infections caused by noncandidal yeasts: species distribution and azole susceptibility

23 New insights into the clinical characteristics and prognostic factors of pulmonary fungal infections from a retrospective study in Southwestern China

24 Liver fungal infections: an overview of the etiology and epidemiology in patients affected or not affected by oncohematologic malignancies

25 Burden and treatment patterns of invasive fungal infections in hospitalized patients in the Middle East: real-world data from Saudi Arabia and Lebanon

26 A critical appraisal of once-daily topical luliconazole for the treatment of superficial fungal infections

27 Prevention of invasive fungal infections in immunocompromised patients: the role of delayed-release posaconazole

28 Profile of isavuconazole and its potential in the treatment of severe invasive fungal infections

29 Safety and efficacy of liposomal amphotericin B for the empirical therapy of invasive fungal infections in immunocompromised patients

30 Update on the optimal use of voriconazole for invasive fungal infections

31 Empowering women: Moving from awareness to action at the immunology of fungal infections Gordon research conference

32 The Burden of Serious Fungal Infections in Kyrgyzstan

33 Management of osteoarticular fungal infections in the setting of immunodeficiency.

34 Aerobic bacterial and fungal infections in peripheral blood stem cell transplants

35 Fungal infections in neutropenia: current problems and chemotherapeutic control.

36 Fungal infections in neutropenia: current problems and chemotherapeutic control

37 Safety and Efficacy of Activated Transfected Killer Cells for Neutropenic Fungal Infections

38 Invasive fungal infections: biomarkers and molecular approaches to diagnosis

39 Aerobic bacterial and fungal infections in peripheral blood stem cell transplants

40 virulence of mixed fungal infections in honey bee brood

41 burden and treatment patterns of invasive fungal infections in hospitalized patients in the middle east: real-world data from saudi arabia and lebanon

42 tratamento pelo fluconazol de pacientes imuno-comprometidos com graves infecções fúngicas treatment by fluconazole of severe fungal infections in immunocompromised patients

43 burden of severe fungal infections in burkina faso

44 clinical safety and tolerability issues in use of triazole derivatives in management of fungal infections

45 the prevalence and pattern of superficial fungal infections among school children in ile-ife, south-western nigeria

46 unusual fungal infections in renal transplant recipients

47 burden of serious fungal infections in argentina

48 economic evaluation of posaconazole versus standard azole therapy as prophylaxis against invasive fungal infections in patients with prolonged neutropenia in canada

49 Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus

50 New spectrum of fungal infections in patients with cancer

51 Strategies to enhance immune function in hematopoietic transplantation recipients who have fungal infections

52 Invasive Bacterial and Fungal Infections Among Hospitalized HIV-Infected and HIV-Uninfected Adults and Adolescents in Northern Tanzania

53 The spectrum of non-Candida fungal infections following bone marrow transplantation

54 Invasive bacterial and fungal infections among hospitalized HIV-infected and HIV-uninfected adults and adolescents in northern Tanzania

55 Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus

56 Immunomodulation with interferon-gamma and colony-stimulating factors for refractory fungal infections in patients with leukemia